Cardiovascular Journal of Africa: Vol 27 No 6 (November/December 2016)

2 / 76

Pharma Dynamics Clopidogrel 75 mg. Each film coated tablet contains clopidogrel hydrogen sulphate equivalent to clopidogrel 75 mg. Reg. No.: RSA S3 42/8.2/0128. NAM NS2 10/7.1/0377. For full prescribing information, refer
to the package insert approved by the Medicines Control Council, October 2008.1) Vs originator clopidogrel. Department of Health website – Accessed 09/04/2015. 2) Poponina TM, et al.Current approaches
to the prevention of thrombotic complications in patients with acute coronary syndrome without ST-segment elevation. Topical issues of heart and vascular diseases. 2009;4:4-9. (English translation) 3) Creager MA. Results of the
CAPRIE trial: efficacy and safety of clopidogrel.Vascular Medicine 1998;3:257-260. 4) COMMIT Collaborative Group.Addition of clopidogrel to aspirin in 45 852 patients with acute myocardial infarction: randomised placebo-controlled
trial. The Lancet 2005;366(9497):1607-1621. 5) Sabatine MS, et al. Addition of Clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. New England Journal of Medicine 2005;352:1179-
89.6) The CURE Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. New England Journal of Medicine 2001;345:494-502. PDCLC203/06/2015
For further product information contact PHARMA DYNAMICS P O Box 30958 Tokai Cape Town 7966
Tel 021 707 7000 Fax 021 701 5898 Email CUSTOMER CARE LINE 0860 PHARMA (742 762)
Shown to reduce the risk of atherosclerotic events
in a wide range of patients with a history of:
• Stroke3,4,6
• PAD3
• STEMI4,5
• Unstable Angina/NSTEMI6
cost e ective1,
clinically proven2 reduction
of atherosclerotic events
A Lupin Group Company